LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $13,282,000 | +9.4% | 85,990 | -1.3% | 1.46% | +4.1% |
Q3 2021 | $12,136,000 | +406.9% | 87,110 | +377.4% | 1.40% | +424.3% |
Q2 2021 | $2,394,000 | +12.3% | 18,245 | +30.5% | 0.27% | +8.5% |
Q1 2021 | $2,132,000 | -74.9% | 13,985 | -77.7% | 0.25% | -78.4% |
Q4 2018 | $8,504,000 | -33.0% | 62,671 | +35.6% | 1.14% | -0.7% |
Q3 2018 | $12,686,000 | -20.7% | 46,217 | -40.2% | 1.15% | -21.8% |
Q2 2018 | $16,004,000 | +14.5% | 77,247 | -8.7% | 1.47% | +7.3% |
Q1 2018 | $13,982,000 | -4.5% | 84,652 | -20.8% | 1.37% | +32.7% |
Q4 2017 | $14,634,000 | -24.1% | 106,887 | -24.5% | 1.03% | -18.6% |
Q3 2017 | $19,283,000 | -8.3% | 141,626 | -18.3% | 1.27% | -9.9% |
Q2 2017 | $21,039,000 | +14.0% | 173,291 | -0.7% | 1.41% | +15.0% |
Q1 2017 | $18,463,000 | +2.2% | 174,456 | -1.9% | 1.23% | +10.3% |
Q4 2016 | $18,064,000 | -14.7% | 177,771 | -14.3% | 1.11% | -10.6% |
Q3 2016 | $21,182,000 | +1.3% | 207,496 | +18.3% | 1.24% | +2.1% |
Q2 2016 | $20,912,000 | – | 175,331 | – | 1.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |